Drawing for QIETIFY

USPTO serial 88519283

QIETIFY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
FERRER PEREZ, PAUL ANTHONY
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with QIETIFY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, autism, auditory diseases and disorders, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, central nervous system diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, fragile x syndrome, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech diseases and disorders, and viral diseases and disordersACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 13, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 13, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 9, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 8, 2022EX5GSOU EXTENSION 5 GRANTED
Jul 8, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 24, 2022EXT5SOU EXTENSION 5 FILED
Jun 24, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 8, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 6, 2022EX4GSOU EXTENSION 4 GRANTED
Jan 6, 2022EXT4SOU EXTENSION 4 FILED
Jan 6, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 2, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 30, 2021EX3GSOU EXTENSION 3 GRANTED
Jun 30, 2021EXT3SOU EXTENSION 3 FILED
Jun 30, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 6, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 4, 2021EX2GSOU EXTENSION 2 GRANTED
Jan 4, 2021EXT2SOU EXTENSION 2 FILED
Jan 4, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 10, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 8, 2020EX1GSOU EXTENSION 1 GRANTED
Jun 8, 2020EXT1SOU EXTENSION 1 FILED
Jun 8, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 7, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 12, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 23, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 3, 2019DOCKASSIGNED TO EXAMINER
Jul 24, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 20, 2019NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance